NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/21/2025
Back to search
Official data from USPTO
STEMCELL ARTS THE ART & SCIENCE OF REGENERATIVE MEDICINE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
52
Latest update
10/22/2025
Trademark type
Combined
Nice classes
40, 42, 44
Filing date
09/06/2013
Registration date
07/07/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/21/2025
Last transaction
10/22/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/31/2013
First use in commerce
01/31/2013
Drawing code
3
Owner type
03
Owner location
Fairfax, VA
Examiner
ULRICH,NANCY G
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a sphere outlined by ribbons with the words "STEM CELL ARTS" in uppercase letters to the right and above the words "THE ART & SCIENCE OF REGENERATIVE MEDICINE" in title case.
Holders and representatives
Holders
Physical Medicine Associates, Ltd.
Representatives
Kevin Oliveira Odin, Feldman & Pittleman PC
Technical classification
Nice Classes
Class 40Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Biomedical servicescryopreservation of human tissuebloodblood components and stem cells for ultimate use in medical treatment and diagnosis
Class 42
Biomedical serviceslaboratory services for human tissuebloodblood components and stem cells for medical use; providing advice and information in the field of medical and scientific research; biological research; scientific development in the field of stem cells and regenerative therapy; medical laboratories; biomedical servicesanalyzing human tissuebloodblood components and stem cells for use in medical treatment and diagnosis; biologic services in the nature of biologic research; providing advice and information in the field of scientific medical research and scientific research in the field of genetic testing
Class 44
Medical services; medical consultations; medical clinics; medical servicesproviding medical treatment to individuals with genetic diseases; providing medical therapies in the nature of infusion therapy services and blood therapy services; biomedical servicescollectingscreening and typing of human tissuebloodblood components and stem cells for ultimate use in medical treatment and diagnosis; biomedical servicestesting of human tissuebloodblood components and stem cells for treating and diagnosing genetic diseases; biomedical storage serviceshuman tissue banksblood banksblood component banks and stem cell banks for medical purposes; autologous blood therapies for the treatment of blood diseases and conditions; medical services in the field of stem cell therapy
Publications
History of USPTO decisions and trademark events.
52 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/21/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/21/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/20/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
07/01/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/07/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/26/2021
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/26/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/26/2021
E815
TEAS SECTION 8 & 15 RECEIVED
05/05/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/07/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
07/07/2015
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/05/2015
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/04/2015
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/17/2015
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/15/2015
IUAF
USE AMENDMENT FILED
04/14/2015
EISU
TEAS STATEMENT OF USE RECEIVED
04/14/2015
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/14/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/17/2015
PUBO
PUBLISHED FOR OPPOSITION
02/17/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/28/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/12/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/12/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/09/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/09/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/09/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/20/2014
GNRT
NON-FINAL ACTION E-MAILED
11/20/2014
CNRT
NON-FINAL ACTION WRITTEN
11/20/2014
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
11/12/2014
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
11/04/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/23/2014
ALIE
ASSIGNED TO LIE
10/20/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/01/2014
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/08/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/08/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/08/2014
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
09/08/2014
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/11/2014
GNFR
FINAL REFUSAL E-MAILED
07/11/2014
CNFR
FINAL REFUSAL WRITTEN
07/11/2014
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/20/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/20/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/20/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/20/2014
CNRT
NON-FINAL ACTION MAILED
12/23/2013
CNRT
NON-FINAL ACTION WRITTEN
12/22/2013
DOCK
ASSIGNED TO EXAMINER
12/18/2013
MDSM
NOTICE OF DESIGN SEARCH CODE MAILED
09/17/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/14/2013
NWAP
NEW APPLICATION ENTERED
09/10/2013
Continuous trademark protection
Get notified about every new filing that threatens STEMCELL ARTS THE ART & SCIENCE OF REGENERATIVE MEDICINE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.